Ken Shimokawa

Ken Shimokawa

Inga fler pågående positioner
Consumer Services
Health Technology
Finance

Profil

Dr. Ken Shimokawa is Senior Investment Director at Astellas Venture Management LLC.
Prior to joining AVM in March 2011, Dr. Shimokawa served as an Associate Director at Department of Licensing & Alliances, Astellas Pharma Inc since October 2010.
He was involved M&A of Japanese Biotech Company, a license-in deal opportunity as well as evaluation of a couple of license-in opportunities.
During 2006-2010, he served as a Global Project Leader for CNS and bone therapeutic area at Project Management, Development, Astellas Pharma Inc. He brought “Bonoteo” for osteoporosis drug in Japanese market, as well as staged up a couple of compounds to P2/3, P1 and P0 in US/EU/JP.
Prior to the GPL, Dr. Shimokawa served as a medicinal and combinatorial chemist to synthesize number of compounds for various therapeutic areas, especially for CNS, Pain and Cardiovascular.
Dr. Shimokawa received a Ph.D.
in Organic Chemistry from the University of Pennsylvania in 1995.

Tidigare kända positioner av Ken Shimokawa

FöretagPositionSlut
Director of Investments 2014-03-31
ASTELLAS PHARMA INC. Företagsledare/Principal -
Se detaljerna i Ken Shimokawas erfarenhet

Ken Shimokawas utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

94

Första gradens relationer

3

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag3

Consumer Services

Health Technology

Finance

  1. Börsen
  2. Insiders
  3. Ken Shimokawa